Literature DB >> 1661584

Tissue distribution of the 1,25-dihydroxyvitamin D3 receptor in the male rat.

M E Sandgren1, M Brönnegärd, H F DeLuca.   

Abstract

Tissue distribution of 1,25-dihydroxyvitamin D3 receptors was studied in male rats using a quantitative immunoradiometric assay. Extracts were prepared from 16 different rat tissues and assayed for 1,25-dihydroxyvitamin D3 receptor. Measurable levels of receptor were detected in intestine, stomach, kidney, bone thyroid/parathyroid, skin, liver, spleen, heart and lung. The highest levels were found in the proximal small intestine and colon, containing over 1000 fmol/mg total protein, while ileum and kidney contained one-half and one-fourth of this amount, respectively. Other parts of the vitamin D endocrine system, including bone, thyroid/parathyroid and skin, contained moderate levels of receptor of 40 to 80 fmol/mg, while lung, heart, stomach, spleen and liver had levels at or below 20 fmol/mg. No 1,25-dihydroxyvitamin D3 receptor was detected in cerebrum, cerebellum or skeletal muscle. The data support a wide-spread role for 1,25-dihydroxyvitamin D3 on cellular processes and suggest a more important role for vitamin D in colon.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1661584     DOI: 10.1016/0006-291x(91)91234-4

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  In vivo target recognition with high-resolution imaging: significance for drug development.

Authors:  Walter E Stumpf
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2010-09       Impact factor: 2.441

2.  Effect of paricalcitol on left ventricular mass and function in CKD--the OPERA trial.

Authors:  Angela Yee-Moon Wang; Fang Fang; John Chan; Yue-Yi Wen; Shang Qing; Iris Hiu-Shuen Chan; Gladys Lo; Kar-Neng Lai; Wai-Kei Lo; Christopher Wai-Kei Lam; Cheuk-Man Yu
Journal:  J Am Soc Nephrol       Date:  2013-09-19       Impact factor: 10.121

Review 3.  Vitamin D deficiency in UK Asian families: activating a new concern.

Authors:  N J Shaw; B R Pal
Journal:  Arch Dis Child       Date:  2002-03       Impact factor: 3.791

4.  Factors involved in the duodenal expression of the human calbindin-D9k gene.

Authors:  N F Barley; S R Prathalingam; P Zhi; S Legon; A Howard; J R Walters
Journal:  Biochem J       Date:  1999-08-01       Impact factor: 3.857

5.  Inappropriate phosphate excretion in idiopathic hypercalciuria: the key to a common cause and future treatment?

Authors:  C P Williams; D F Child; P R Hudson; L D Soysa; G K Davies; M G Davies; A R De Bolla
Journal:  J Clin Pathol       Date:  1996-11       Impact factor: 3.411

Review 6.  The development of a bone- and parathyroid-specific analog of vitamin D: 2-methylene-19-Nor-(20S)-1α,25-dihydroxyvitamin D3.

Authors:  Hector F Deluca
Journal:  Bonekey Rep       Date:  2014-03-05

7.  Administration of alfacalcidol for patients with predialysis chronic kidney disease may reduce cardiovascular disease events.

Authors:  Sachiyo Sugiura; Daijo Inaguma; Akimitsu Kitagawa; Minako Murata; Yutaka Kamimura; Sho Sendo; Kyoko Hamaguchi; Hiroshi Nagaya; Miho Tatematsu; Kei Kurata; Yukio Yuzawa; Seiichi Matsuo
Journal:  Clin Exp Nephrol       Date:  2009-10-31       Impact factor: 2.801

8.  Low levels of 25-hydroxyvitamin D in the pediatric populations: prevalence and clinical outcomes.

Authors:  Michal L Melamed; Juhi Kumar
Journal:  Ped Health       Date:  2010-02

9.  Relationship between serum 1,25-dihydroxyvitamin D and mortality in patients with pre-dialysis chronic kidney disease.

Authors:  Daijo Inaguma; Hiroshi Nagaya; Kazuhiro Hara; Miho Tatematsu; Hibiki Shinjo; Sachiyo Suzuki; Tomoko Mishima; Kei Kurata
Journal:  Clin Exp Nephrol       Date:  2008-01-09       Impact factor: 2.801

Review 10.  CKD-MBD: impact on management of kidney disease.

Authors:  Hiroaki Ogata; Fumihiko Koiwa; Eriko Kinugasa; Tadao Akizawa
Journal:  Clin Exp Nephrol       Date:  2007-12-21       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.